Stocks and Investing Stocks and Investing
Wed, November 16, 2022
Tue, November 15, 2022
Mon, November 14, 2022

Joseph Schwartz Maintained (ANTX) at Buy with Decreased Target to $25 on, Nov 14th, 2022


Published on 2024-10-28 00:09:23 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "AN2 Therapeutics, Inc." (ANTX) at Buy with Decreased Target from $27 to $25 on, Nov 14th, 2022.

Joseph, nor any peers, have made any analyst calls on ANTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30